SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...

September is Prostate Cancer Awareness Month. Mississippi has one of the highest prostate cancer mortality rates in the ...

Prostate cancer is one of the most common cancers in men. About one in eight men will be diagnosed with prostate cancer ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

New technologies and treatment methods are expanding men’s options. Here’s what you should know about your choices for ...

Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months ...

In honor of Prostate Cancer Awareness Month in September, Cleveland Diagnostics has proudly relaunched its PSA on PSA ...

“This study adjusted for testosterone levels, which can influence PSA and outcomes, and still found a significant association. This strengthens the argument that PSA response to neoadjuvant therapy is ...

Discover a study showing that biparametric MRI is as effective as multiparametric MRI in detecting clinically significant ...

Use of PSMA PET/CT imaging before salvage radiotherapy was linked to improved survival for patients with BCR prostate cancer ...

Jesse Bennett, a two-time prostate cancer survivor and Morgan State University health education graduate, uses his journey to inspire other men to take charge of their health by learning their PSA ...